Dr. Agarwal Healthcare IPO: The IPO for Dr. Agarwal Healthcare is scheduled to list on the BSE and NSE on Wednesday, 5th February 2025. Let’s know more about the Dr. Agarwal Healthcare IPO and it’s review in detail.
Overview of Dr. Agarwal Healthcare Limited
The goal at Dr. Agarwal’s Health Care Limited is to use knowledge and creativity to improve healthcare. Their extensive network of medical facilities is manned by skilled specialists and furnished with cutting-edge equipment. Their operations are centered on openness and good communication with their stakeholders, which guarantees that investors are aware of their progress and are optimistic about their future. They always work to establish new standards in healthcare, with an emphasis on growing their offerings and improving patient results. Join along with them as they strive to enhance lives in the communities, they serve by offering high-quality healthcare services.
Details of Dr. Agarwal Healthcare IPO
Key details of the Dr. Agarwal Healthcare IPO are listed below:
Opening Date of the IPO | 29 January, 2025 |
Closing Date of the IPO | 31 January, 2025 |
Listed at | NSE, BSE |
Issue type | Book Built issue |
Face value | ₹1 per share |
Lot size | 35 Shares |
Price Brand | ₹382 to ₹402 per share |
Dr. Agarwal Healthcare IPO Review
Investor reaction to Dr. Agarwal Health Care’s first public offering (IPO), which went live on 29th January 2025, Wednesday, has been largely subdued. Moreover, yesterday, 31 January 2025, marked the end of the public offering’s three-day subscription period. According to information available on the National Stock Exchange (NSE), the bids received by Dr. Agarwal’s Health Care IPO were 2,25,71,920 equity shares against the 5,35,26,172 shares on offer. The shares were available at a price range of Rs 308-402 per share with a lot size of 35 shares. This resulted in a subscription of 0.42 times by the end of January 30.
Dr. Agarwal Healthcare IPO GMP
Analysts report that the Dr. Agarwal IPO GMP premium was ₹0 today, meaning that shares were trading with a discount on the gray market or zero premium at their issue price of ₹402. The IPO GMP is now trending lower and seems to be headed for additional drops, given the performance of the grey market during the last nine sessions. Several specialists have observed that the GMP recorded ranges from a minimum of 0.00 to a maximum of ₹54.
Moreover, the Dr. Agarwal Healthcare initial public offering (IPO) share distribution is scheduled to be finalized on 3rd February, Monday. The Dr. Agarwal’s IPO allotment status is available to investors who applied through the portal of registrars, i.e., through Kfin Technologies Ltd.
Conclusion
After a sluggish start, the Dr. Agarwal Healthcare IPO was completely subscribed on the last day. NIIS (non-institutional investors), retail investors, and qualified institutional buyers (QIBs) showed a fair amount of interest.
For more such insights, check out the Angelone application, wherein you can create your Demat account with a single tap and start your investor journey instantly.
Disclaimer: Demat Dive is not giving any buying advice on any stock. Consult a SEBI-registered advisor before investing anywhere.